SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Mylan, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline -- MYL

NEW YORK, Sept. 1, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who voted their shares of Mylan, Inc. MYL in connection with the January 29, 2015 stockholder vote of Mylan, Inc.

You are hereby notified that a class action has commenced in the USDC for the Western District of Pennsylvania. To learn more go to:

http://zlk.9nl.com/mylan

or contact Joseph E. Levi, Esq. via email at jlevi@zlk.com or by telephone at (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that Mylan, Inc. breached its fiduciary duties to shareholders in connection with the acquisition of Mylan by Abbott Laboratories. In particular, the complaint alleges that Mylan's Definitive Proxy Statement issued in connection with the January 29, 2015 stockholder vote contained material misstatements and omissions regarding the potential consequences of the Abbott merger and the Company's re-incorporation in the Netherlands, including falsely representing that Mylan would be bound by and would comply with NASDAQ Global Select Market's listing rules. The complaint further alleges that the misleading Proxy Statement allowed Mylan's Board to entrench themselves in their positions while simultaneously destroying shareholder value by staving off a potential acquisition by Teva Pharmaceutical Industries Ltd.

If you suffered a loss in Mylan, Inc. you have until November 2, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you be a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise and experience in representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.